ACROBiosystems

What ACROBiosystems does

ACROBiosystems is a publicly traded (SZSE: 301080) biotechnology tools company founded in 2010 that manufactures recombinant proteins, antibodies, cell lines, ELISA kits, and GMP-grade raw materials primarily for biopharmaceutical drug discovery and cell and gene therapy (CGT) manufacturing. The company's product portfolio spans eight branded sub-lines — ActiveMax (cell activation beads), CelThera (serum-free media), GENIUS (nucleases), GENPower (CRISPR-Cas enzymes), resDetect (residual detection), SAFENSURE (safety testing), Star Staining (fluorescent labeling), and Aneuro (neuroscience proteins) — covering the full research-to-clinical workflow for CAR-T, CAR-NK, TCR-T, ADC, gene therapy, and iPSC applications. Manufacturing is anchored at a 50,000+ square meter GMP facility in Suzhou, China (operational since June 2024) with ISO 9001, GMP, Rx-360, MDSAP, and ADR certifications, complemented by regional headquarters in Newark, Delaware (North America) and Zug, Switzerland (Europe), with offices across 15 cities and distribution in 30+ countries.

The company's revenue model combines one-time catalog sales of research-use reagents with quote-based pricing for custom GMP-grade proteins and cell therapy raw materials, plus licensing (notably HEK293 functional cell lines) and fee-for-service analytical testing. Go-to-market is sales-led, leveraging direct enterprise relationships with global pharmaceutical companies (Pfizer, Novartis, Johnson & Johnson, Roche, AstraZeneca, AbbVie, Takeda, Boehringer Ingelheim), regional sales teams in the US, Europe, and Asia-Pacific, and distribution partnerships with Fisher Scientific and VWR. The company is investing in AI-driven protein engineering via the proprietary Acro-AIx system, which has demonstrated a 20-fold increase in protein expression yield, and recently secured PMDA Material Suitability Confirmation for GMP-grade IL-15 in Japan, signaling international regulatory expansion.

Name

ACROBiosystems

Legal name

ACROBiosystems

Website

https://acrobiosystems.com

Company type

Public

Founded year

2010

Operating status

Operating

Headcount range

251–500 employees

Short description

ACROBiosystems is a publicly traded biotechnology tools company that manufactures recombinant proteins, antibodies, cell lines, and GMP-grade raw materials for biopharmaceutical drug discovery and cell and gene therapy manufacturing, serving global pharmaceutical companies and biotech firms across 30+ countries.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)

akta.pro secondary industries

Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

Keywords

• Recombinant proteins
• GMP biological reagents
• Cell and gene therapy
• Antibody drug conjugate
• Biopharmaceutical tools

Headquarters

HQ city

Newark

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Revenue model

1. Recombinant Protein Sales: Sale of recombinant proteins including cytokines, growth factors, enzymes, immune checkpoints, and GMP-grade materials for biopharmaceutical research and cell therapy manufacturing.
2. Antibody Products: Sale of antibodies including immunohistochemistry antibodies, anti-idiotype antibodies, anti-payload antibodies, and isotype controls.
3. Cell Lines: Sale of functional cell lines including reporter cell lines, overexpression cell lines, and knockout cell lines. Global commercial license assistance provided for regulatory filings.
4. Kits and Assay Reagents: ELISA kits, qPCR kits, fluorescence assay kits, flow cytometry kits, and ADC conjugation kits for drug discovery and quality control.
5. Cell Culture Reagents: GMP-grade growth factors, extracellular matrix proteins, serum-free cell culture media, magnetic beads, and nucleases for cell therapy manufacturing.
6. Custom Development Services: Custom GMP-grade protein services, cell line customization, MHC complex services, ELISA services, SPR/BLI analytical services, and TR-FRET kit development.
7. Analytical Testing Services: SAFENSURE safety testing services including endotoxin testing, mycoplasma qPCR testing, sterility testing, and quality characterization services.
8. Licensing Solutions: HEK293 functional cell line licensing with purchase-based authorization model embedding IP clearance into procurement, with exclusions for Greater China region.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

ACROBiosystems manufactures and sells recombinant proteins, antibodies, cell lines, kits, and GMP-grade raw materials for biopharmaceutical research, antibody drug development, and cell and gene therapy applications. The company supplies critical reagents and quality raw materials used by biopharmaceutical companies in drug discovery, development, and manufacturing workflows.

Product overview

ACROBiosystems is a biotechnology company founded in 2010 offering a comprehensive portfolio of recombinant proteins, antibodies, cell lines, kits, and GMP-grade reagents for biopharmaceutical research and cell and gene therapy development. The product ecosystem centers on core reagent categories (Recombinant Proteins, Antibodies, Cell Lines, ELISA Kits, Viral Antigens) supported by specialized sub-brands including ActiveMax (magnetic cell activation beads), CelThera (cell expansion media), GENIUS Nuclease (residual nucleic acid removal), GENPower (CRISPR-Cas enzymes), SAFENSURE (safety testing), resDetect (residual detection kits), and Star Staining (fluorescent labeling). The company provides end-to-end solutions from research through clinical manufacturing, with GMP-grade capabilities at its Suzhou facility for cell and gene therapy raw material supply.

Differentiator

Problem solved

Functional benefit

Brands

• ActiveMax: Brand for cell culture grade magnetic beads including CD3/CD28 beads, CD19 beads, BCMA beads, and DLL4 beads.
• Aneuro
• CelThera
• CytoPak
• GENIUS
• GENPower
• Resilient Supply
• resDetect
• SAFENSURE
• Star Staining
• Star Ribbon

Products and services

• Recombinant Proteins Recombinant proteins manufactured for biopharmaceutical research and drug development applications, used by pharma and biotech companies.
• Antibodies Antibodies supplied for biopharmaceutical research and therapeutic development workflows.
• Cell Lines Cell lines developed for biopharmaceutical research and cell therapy applications.
• Kits Assay and reagent kits for biopharmaceutical research and drug development applications.
• GMP-Grade Raw Materials GMP-compliant raw materials for cell and gene therapy manufacturing and antibody drug conjugate production, used by biopharmaceutical manufacturers.

Quantifiable outcome

• 20-fold increase in expression yield through AI-powered protein engineering
• +3 more outcomes

Named customers14 records

Segments7 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

Partnerships

14 partnerships are on record, tiered minor, major and core.

• Fisher ScientificminorChannel Partner/ Reseller/ Distributor · 14 July 2026Distribution partner listing ACROBiosystems cell line products including CD20 knockout cell line on fisher scientific website.
• VWRminorChannel Partner/ Reseller/ Distributor · 14 July 2026Distribution partner listing ACROBiosystems products through VWR website search functionality.
• Roche/GenentechmajorStrategic or Co-development Partner · 13 July 2026Roche/Genentech executives participate in BIOSeedin partnering summits where licensing trends, M&A opportunities, and innovation strategies are discussed. Part of ongoing strategic dialogue.
• AstraZenecamajorStrategic or Co-development Partner · 13 July 2026AstraZeneca participates in panel discussions at BIOSeedin summits exploring oncology and autoimmune innovation strategies with Chinese biotech partners.
• TakedamajorStrategic or Co-development Partner · 13 July 2026Takeda participates as panel executives at BIOSeedin Summer Summit discussing global licensing and innovation strategies.
• Boehringer IngelheimmajorStrategic or Co-development Partner · 13 July 2026Executive representation at BIOSeedin partnering summit exploring global innovation and licensing opportunities.
• Daiichi SankyomajorStrategic or Co-development Partner · 13 July 2026Daiichi Sankyo executives participate in panel discussions at partnering summit focused on late-stage clinical pipelines and licensing transactions.
• Otsuka PharmaceuticalminorStrategic or Co-development Partner · 13 July 2026Executive participation at partnering summit representing Japanese pharmaceutical industry perspectives.
• Sun PharmaminorStrategic or Co-development Partner · 13 July 2026Indian pharmaceutical company representation at partnering summit discussing licensing and M&A trends.
• ServierminorStrategic or Co-development Partner · 13 July 2026French pharmaceutical company participation in partnering summit discussions.
• PfizercoreStrategic or Co-development Partner · 9 May 2026Pfizer is identified as a strategic partner in drug discovery and development. ACROBiosystems provides global licensing solutions and protein products to support Pfizer's biopharmaceutical R&D operations.
• NovartiscoreStrategic or Co-development Partner · 9 May 2026Novartis partners with ACROBiosystems utilizing the global licensing solution for HEK293 functional cell lines. The partnership supports Novartis' internal research and drug discovery programs.
• Johnson & JohnsoncoreStrategic or Co-development Partner · 9 May 2026Johnson & Johnson is identified as a strategic partner. ACROBiosystems supports J&J's biopharmaceutical innovation through product supply and partnership summits.
• AbbViemajorStrategic or Co-development Partner · 11 January 2026AbbVie executives participate in bioSeedin JPM Spotlight discussions on oncology, cardio-renal-metabolic, and autoimmunity therapeutic areas.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Bio-Techne: Bio-Techne is a leading US-based supplier of recombinant proteins, antibodies, and reagents for life science research and bioprocessing. It directly competes with ACROBiosystems across recombinant proteins, GMP cytokines, and cell therapy reagents, with a much larger catalog and broader distribution.
• Sino Biological: Sino Biological is a Chinese-headquartered recombinant protein and antibody manufacturer with a catalog comparable to ACROBiosystems, including cytokines, growth factors, and viral antigens. It is a direct competitor especially across research-grade reagents and increasingly in GMP-grade offerings for CGT developers.
• Miltenyi Biotec: Miltenyi Biotec provides GMP-grade reagents, cell activation beads (similar to ActiveMax), and cell therapy manufacturing solutions. Its MACS GMP portfolio and CliniMACS platform compete directly with ACROBiosystems' cell therapy raw materials and HEK293-based offerings.
• GenScript: GenScript is a global biotechnology tools company offering recombinant proteins, gene synthesis, peptide services, and cell therapy reagents. Its Life Science research reagents business directly overlaps with ACROBiosystems' core recombinant protein and antibody catalog.

Broad incumbents

• Cytiva: Cytiva (a Danaher company) is a broad incumbent in bioprocessing and cell/gene therapy manufacturing, offering consumables, reagents, and instrumentation that overlap with ACROBiosystems' GMP raw materials and process reagents. While much larger and broader, Cytiva competes for the same CGT manufacturing wallet.
• Lonza: Lonza is a major CDMO and bioprocessing supplier with GMP-grade raw materials and cell therapy manufacturing services. While primarily a CDMO, Lonza competes with ACROBiosystems in supplying GMP-grade cytokines and cell therapy process materials to large pharma customers.
• PeproTech (Thermo Fisher Scientific): PeproTech, now part of Thermo Fisher Scientific, is one of the original recombinant cytokine and growth factor suppliers. Following integration into Thermo Fisher's life sciences portfolio, PeproTech products directly compete with ACROBiosystems' recombinant protein and GMP cytokine offerings at research and process scale.
• Abcam (Danaher): Abcam, now part of Danaher, is a leading global supplier of research-grade antibodies and reagents. While more focused on antibodies than ACROBiosystems' full portfolio, Abcam directly overlaps in IHC antibodies, anti-idiotype antibodies, and recombinant antibody tools for pharma R&D.

Emerging players

• CellGenix: CellGenix is a Germany-headquartered supplier of GMP-grade raw materials for cell and gene therapy, including cytokines, growth factors, and cell culture media. It is a focused direct peer to ACROBiosystems' GMP raw materials portfolio serving CAR-T and TCR-T developers in Western markets.
• Novoprotein Scientific: Novoprotein is a Chinese recombinant protein manufacturer offering cytokines, growth factors, and custom protein services at competitive price points. It is an emerging direct peer competing with ACROBiosystems in research-grade recombinant proteins globally and in GMP-grade offerings for the Chinese CGT market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ACROBio

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACROBiosystems